Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morihito Okada

Showing results (191-200 of 527) with videos related to

Pageof 53
Sort By:
JTCVS Open|August 25, 2022
A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non-small cell lung cancer (JCOG 0707)Hideo Kunitoh, Masahiro Tsuboi, Masashi Wakabayashi, et al.
Clinical Breast Cancer|October 11, 2017
Role of <sup>18</sup>F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant ChemotherapyEtsushi Akimoto, Takayuki Kadoya, Keiko Kajitani, et al.
Clinical and Translational Medicine|September 15, 2017
Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patientsRyungsa Kim, Ami Kawai, Megumi Wakisaka, et al.
Cancer|January 22, 2013
Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I non-small cell lung cancerHiroaki Harada, Kazuaki Miyamoto, Yoshinori Yamashita, et al.
Anticancer Research|July 31, 2013
Treatment outcomes and prognostic factors for thoracic esophageal cancer with clinical evidence of adjacent organ invasionYoichi Hamai, Jun Hihara, Manabu Emi, et al.
Thorax|October 5, 2013
Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysemaTakahiro Mimae, Man Hagiyama, Takao Inoue, et al.
Anticancer Research|October 7, 2017
Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell CarcinomaYoichi Hamai, Jun Hihara, Manabu Emi, et al.
Japanese Journal of Clinical Oncology|June 10, 2015
Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypesTakahiro Mimae, Yoshihiro Miyata, Takeshi Mimura, et al.
Japanese Journal of Clinical Oncology|January 10, 2009
A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesotheliomaTakeharu Yamanaka, Fumihiro Tanaka, Seiki Hasegawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2011
Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stagesTakahiro Mimae, Morihito Okada, Man Hagiyama, et al.
Pageof 53

Showing results (191-200 of 527) with videos related to

Sort By:
Pageof 53
JTCVS Open|August 25, 2022
A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non-small cell lung cancer (JCOG 0707)Hideo Kunitoh, Masahiro Tsuboi, Masashi Wakabayashi, et al.
Clinical Breast Cancer|October 11, 2017
Role of <sup>18</sup>F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant ChemotherapyEtsushi Akimoto, Takayuki Kadoya, Keiko Kajitani, et al.
Clinical and Translational Medicine|September 15, 2017
Differences in immune response to anesthetics used for day surgery versus hospitalization surgery for breast cancer patientsRyungsa Kim, Ami Kawai, Megumi Wakisaka, et al.
Cancer|January 22, 2013
Methylation of breast cancer susceptibility gene 1 (BRCA1) predicts recurrence in patients with curatively resected stage I non-small cell lung cancerHiroaki Harada, Kazuaki Miyamoto, Yoshinori Yamashita, et al.
Anticancer Research|July 31, 2013
Treatment outcomes and prognostic factors for thoracic esophageal cancer with clinical evidence of adjacent organ invasionYoichi Hamai, Jun Hihara, Manabu Emi, et al.
Thorax|October 5, 2013
Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysemaTakahiro Mimae, Man Hagiyama, Takao Inoue, et al.
Anticancer Research|October 7, 2017
Effects of Neoadjuvant Chemoradiotherapy on Pathological TNM Stage and Their Prognostic Significance for Surgically-treated Esophageal Squamous Cell CarcinomaYoichi Hamai, Jun Hihara, Manabu Emi, et al.
Japanese Journal of Clinical Oncology|June 10, 2015
Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypesTakahiro Mimae, Yoshihiro Miyata, Takeshi Mimura, et al.
Japanese Journal of Clinical Oncology|January 10, 2009
A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesotheliomaTakeharu Yamanaka, Fumihiro Tanaka, Seiki Hasegawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 23, 2011
Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stagesTakahiro Mimae, Morihito Okada, Man Hagiyama, et al.
Pageof 53